Synthesis and biological evaluation of Bis-2-(1,3,8-triazaspiro[4,5]decan-4-one)ethylamine based radiopharmaceuticals for neuroendocrine tumor

被引:0
作者
Sethi, S. K. [1 ]
Varshney, R. [1 ]
Hazari, P. P. [1 ]
Milton, M. D. [2 ]
Mishra, A. K. [1 ]
机构
[1] Inst Nucl Med & Allied Sci, Delhi, India
[2] Univ Delhi, Delhi 110007, India
关键词
D O I
暂无
中图分类号
R8 [特种医学]; R445 [影像诊断学];
学科分类号
1002 ; 100207 ; 1009 ;
摘要
引用
收藏
页码:S296 / S296
页数:1
相关论文
共 50 条
[11]   Synthesis of [123I]-8-[4-[2-(5-iodothienyl)]-4-oxobutyl]-3-methyl-1-phenyl-1,3,8-triazaspiro[4.5]decan-4-one:: A potential dopamine D2 receptor radioligand for SPECT [J].
Waterhouse, RN ;
Gotsick, JT ;
Kabalka, GW ;
Goodman, MM ;
O'Brien, JC .
JOURNAL OF LABELLED COMPOUNDS & RADIOPHARMACEUTICALS, 1998, 41 (05) :363-376
[12]   8-[1-(4-METHYLPHENYL)ETHYL]-1-PHENYL-1,3,8-TRIAZASPIRO[4.5]DECAN-4-ONE1/2 METHANOL - R 6372 [J].
HUMBLET, C ;
BURNOTTE, C ;
EVRARD, G ;
DURANT, F .
ACTA CRYSTALLOGRAPHICA SECTION B-STRUCTURAL SCIENCE, 1978, 34 (DEC) :3830-3832
[13]   In vivo evaluation of [I-123]-8-[4-[2-(5-iodothienyl)]-4-oxobutyl]-3-methyl-1-phenyl-1,3,8-triazaspiro[4.5]decan-4-one as a potential dopamine D-2 receptor radioligand for SPECT [J].
Waterhouse, RN ;
Gotsick, JT ;
Kabalka, GW ;
Goodman, MM ;
OBrien, JC .
NUCLEAR MEDICINE AND BIOLOGY, 1998, 25 (01) :77-80
[14]   SYNTHESIS AND EVALUATION OF F-18 LABELED 3-(2-FLUOROETHYL)-8-[4-(2' THIENYL)-4-OXO-BUTYL]-1-PHENYL-1,3,8-TRIAZASPIRO[4.5]DECAN-4-ONE AS A POTENTIAL CNS D2 RECEPTOR IMAGING AGENT [J].
GOODMAN, MM ;
SHI, BZ ;
KABALKA, GW ;
GOTTSICK, T .
ABSTRACTS OF PAPERS OF THE AMERICAN CHEMICAL SOCIETY, 1994, 208 :57-NUCL
[15]   Synthesis and biological evaluation of F-18 labeled 8-(3-(4-(3-fluoropropyl)-1H-1,2,3-triazol-1-yl)propyl)-1-phenyl-1,3,8-triazaspiro[4.5]decan-4-one for PET imaging of D2 receptor. [J].
Sethi, S. K. ;
Varshney, R. ;
Sandhya, R. ;
Milton, M. D. ;
Mishra, A. K. .
EUROPEAN JOURNAL OF NUCLEAR MEDICINE AND MOLECULAR IMAGING, 2013, 40 :S421-S421
[16]   8-[4-(4-FLUOROPHENYL)-3-PENTENYL]-1-PHENYL-1,3,8-TRIAZA-SPIRO[4,5]DECAN-4-ONE(SPIRILENE) [J].
KOCH, MHJ ;
EVRARD, G .
ACTA CRYSTALLOGRAPHICA SECTION B-STRUCTURAL SCIENCE, 1973, 29 (DEC15) :2971-2973
[17]   Anticancer Activity of Spirocyclic Hydroxamic Acids (Derivatives of 1-Hydroxy-1,4,8-Triazaspiro[4,5]Decan-2-One), Histone Deacetylase Inhibitors [J].
N. P. Akentieva ;
A. R. Gizatullin ;
S. A. Goncharova ;
T. A. Raevskaya ;
N. S. Goryachev ;
N. I. Shkondina ;
T. R. Prichodchenko ;
I. V. Vystorop ;
S. S. Shushanov .
Biochemistry (Moscow), Supplement Series A: Membrane and Cell Biology, 2019, 13 :12-23
[18]   Anticancer Activity of Spirocyclic Hydroxamic Acids (Derivatives of 1-Hydroxy-1,4,8-Triazaspiro[4,5]Decan-2-One), Histone Deacetylase Inhibitors [J].
Akentieva, N. P. ;
Gizatullin, A. R. ;
Goncharova, S. A. ;
Raevskaya, T. A. ;
Goryachev, N. S. ;
Shkondina, N. I. ;
Prichodchenko, T. R. ;
Vystorop, I. V. ;
Shushanov, S. S. .
BIOCHEMISTRY MOSCOW SUPPLEMENT SERIES A-MEMBRANE AND CELL BIOLOGY, 2019, 13 (01) :12-23
[19]   Anticancer Activity of Spirocyclic Hydroxamic Acids (Derivatives of 1-Hydroxy-1,4,8-Triazaspiro[4,5]Decan-2-One), Histone Deacetylase Inhibitors [J].
Akentieva, N. P. ;
Gizatullin, A. R. ;
Goncharova, S. A. ;
Raevskaya, T. A. ;
Goryachev, N. S. ;
Shkondina, N., I ;
Prichodchenko, T. R. ;
Vystorop, I. V. ;
Shushanov, S. S. .
BIOLOGICHESKIE MEMBRANY, 2018, 35 (06) :424-437
[20]   Novel Synthesis and Pharmacological Characterization of NOP Receptor Agonist 8-[(1S,3aS)-2,3,3a,4,5,6-Hexahydro-1H-phenalen-1-yl]-1-phenyl-1,3,8-triazaspiro[4.5]decan-4-one (Ro 64-6198) [J].
Chang, Steven D. ;
Brieaddy, Lawrence E. ;
Harvey, Joseph D. ;
Lewin, Anita H. ;
Mascarella, S. Wayne ;
Seltzman, Herbert H. ;
Reddy, P. Anantha ;
Decker, Ann M. ;
McElhinny, Charles J., Jr. ;
Zhong, Desong ;
Peterson, Elisha E. ;
Navarro, Hernan A. ;
Bruchas, Michael R. ;
Carroll, F. Ivy .
ACS CHEMICAL NEUROSCIENCE, 2015, 6 (12) :1956-1964